Skip to main content
. 2019 Nov 19;3(6):e320. doi: 10.1097/HS9.0000000000000320

Figure 2.

Figure 2

Overall survival according to the phase of treatment (The 1-year OS rates were 55.1%, 82.9%, 25.3%, and 44.2% using ISV during induction, consolidation, salvage/BSC and alloSCT, respectively).